Articles

Alvotech To Be The Global Frontrunner For Stelara Biosimilars Following Approval Of Selarsdi In US

Pharmaceuticals / United States / Fri 19 Apr, 2024

Key View 

  • Alvotech will be the global frontrunner for ustekinumab biosimilars following its latest approval of Selarsdi in the US.  
  • Johnson & Johnson will delay new entrants with ongoing patent litigation settlements, although the 2024 and 2025 patent cliffs are quickly approaching.  
  • Stelara revenue will be impacted immediately following biosimilar
Read More

Non-Oil Sector Growth And Health Insurance Reform To Bolster UAE’s Pharmaceutical Sector

Pharmaceuticals / United Arab Emirates / Wed 17 Apr, 2024

Key View

  • Sustained focus on economic diversification will strengthen the UAE's pharmaceutical sector.
  • Rollout of mandatory private health insurance will boost pharmaceutical sales in the UAE.
  • High consumer spending power and brand loyalty will limit pace of generic drug uptake.

Sustained focus on economic diversification will strengthen the UAE's

Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.